Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 2656 AL 2670

Chronic impairment of the vagus nerve function leads to inhibition of dopamine but not serotonin neurons in rat brain structures

Ziomber A, Thor P, Krygowska-Wajs A, Załęcki T, Moskała M, Romańska I, Michaluk J, Antkiewicz-Michaluk L.

Pharmacol Rep. 2012;64(6):1359-67. doi: 10.1016/s1734-1140(12)70933-7.

Parkinson's disease: recent advances

Pandey S.

J Assoc Physicians India. 2012 Jun;60:30-2.

Assessment of speech in neurological disorders: development of a Swahili screening test

Miller N, Mshana G, Msuya O, Dotchin C, Walker R, Aris E.

S Afr J Commun Disord. 2012 Dec;59:27-33.

Fluoxetine does not impair motor function in patients with Parkinson's disease: correlation between mood and motor functions with plasma concentrations of fluoxetine/norfluoxetine

Kostić V, Dzoljić E, Todorović Z, Mijajlović M, Svetel M, Stefanova E, Dragasević N, Petrović I, Milosević M, Kovacević I, Miljković B, Pokrajac M, Prostran M.

Vojnosanit Pregl. 2012 Dec;69(12):1067-75.

[Indexes of integrative activity of motor system in norm and at neuromotor pathology]

Aleksanian ZA, Romanov SP.

Ross Fiziol Zh Im I M Sechenova. 2012 Nov;98(11):1416-31.

New molecular targets for PET and SPECT imaging in neurodegenerative diseases

Benadiba M, Luurtsema G, Wichert-Ana L, Buchpigel CA, Busatto Filho G.

Braz J Psychiatry. 2012 Oct;34 Suppl 2:S125-36. doi: 10.1016/j.rbp.2012.07.002.

Different approaches, one target: understanding cellular mechanisms of Parkinson's and Alzheimer's diseases

Torrão AS, Café-Mendes CC, Real CC, Hernandes MS, Ferreira AF, Santos TO, Chaves-Kirsten GP, Mazucanti CH, Ferro ES, Scavone C, Britto LR.

Braz J Psychiatry. 2012 Oct;34 Suppl 2:S194-205. doi: 10.1016/j.rbp.2012.08.004.

Recognition and treatment of neurologic Wilson's disease

Lorincz MT.

Semin Neurol. 2012 Nov;32(5):538-43. doi: 10.1055/s-0033-1334476. Epub 2013 May 15.

[Future drug targets for Parkinson's disease]

Hirsch EC.

Bull Acad Natl Med. 2012 Oct;196(7):1369-77; discussion 1377-9.

Pramipexole

2017 Jul 20. LiverTox®: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.

Apomorphine

2017 Jul 20. LiverTox®: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.

Pergolide

2017 Jul 20. LiverTox®: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.

Bromocriptine

2017 Jul 20. LiverTox®: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.

Rasagiline

2017 Jul 21. LiverTox®: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.

Rotigotine

2017 Jul 21. LiverTox®: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias